Quantitative dynamic models of arthritis progression in the rat
- PMID: 18758921
- PMCID: PMC3725549
- DOI: 10.1007/s11095-008-9711-3
Quantitative dynamic models of arthritis progression in the rat
Abstract
Purpose: This comparison employs mathematical disease progression models to identify a rat model of arthritis with the least inter-animal variability and features lending to better study designs.
Methods: Arthritis was induced with either collagen (CIA) or mycobacterium (AIA) in either Lewis or Dark Agouti (DA) rats. Disease progression was monitored by paw edema and body weight. Models with production, loss, and feedback components were constructed and population analysis using NONMEM software was employed to identify inter-animal variability in the various disease progression parameters.
Results: Onset time was the only parameter different within all four groups (DA-AIA 11.5 days, DA-CIA 16.5 days, Lewis-AIA 11.9 days, Lewis-CIA 13.9 days). The loss-of-edema rate constant was 20% slower in DA (0.362 h(-1)) than Lewis (0.466 h(-1)) rats. Most models exhibited peak paw edema 20 days post-induction. Edema in CIA returned to 150% of the initial value after the disease peaked. DA rats displayed more severe overall responses.
Conclusions: No statistical differences between groups were observed for inter-animal variation in disease onset, progression and severity parameters. Onset time varies and should be noted in the design of future studies. DA rats may offer a more dynamic range of edema response than Lewis rats.
Figures




Similar articles
-
Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats.Jpn J Pharmacol. 1997 Aug;74(4):313-22. doi: 10.1254/jjp.74.313. Jpn J Pharmacol. 1997. PMID: 9307327
-
Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats.J Pharmacol Exp Ther. 2008 Aug;326(2):532-45. doi: 10.1124/jpet.108.137372. Epub 2008 Apr 30. J Pharmacol Exp Ther. 2008. PMID: 18448865 Free PMC article.
-
Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis.J Pharmacokinet Pharmacodyn. 2011 Dec;38(6):769-86. doi: 10.1007/s10928-011-9219-z. Epub 2011 Oct 16. J Pharmacokinet Pharmacodyn. 2011. PMID: 22002845 Free PMC article.
-
Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach.J Pharmacokinet Pharmacodyn. 2013 Dec;40(6):701-12. doi: 10.1007/s10928-013-9341-1. J Pharmacokinet Pharmacodyn. 2013. PMID: 24233383 Free PMC article.
-
Susceptibility to autoimmune disease and drug addiction in inbred rats. Are there mechanistic factors in common related to abnormalities in hypothalamic-pituitary-adrenal axis and stress response function?Ann N Y Acad Sci. 2000;917:784-96. doi: 10.1111/j.1749-6632.2000.tb05444.x. Ann N Y Acad Sci. 2000. PMID: 11268408 Review.
Cited by
-
Pharmacokinetic/pharmacodynamic modeling in inflammation.Crit Rev Biomed Eng. 2012;40(4):295-312. doi: 10.1615/critrevbiomedeng.v40.i4.50. Crit Rev Biomed Eng. 2012. PMID: 23140121 Free PMC article. Review.
-
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.Clin Pharmacol Ther. 2017 Jun;101(6):745-753. doi: 10.1002/cpt.576. Epub 2017 Feb 9. Clin Pharmacol Ther. 2017. PMID: 27859030 Free PMC article.
-
Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen.Drug Metab Dispos. 2017 Jul;45(7):834-845. doi: 10.1124/dmd.117.075614. Epub 2017 Apr 17. Drug Metab Dispos. 2017. PMID: 28416614 Free PMC article.
-
A rat liver cell atlas reveals intrahepatic myeloid heterogeneity.iScience. 2023 Oct 14;26(11):108213. doi: 10.1016/j.isci.2023.108213. eCollection 2023 Nov 17. iScience. 2023. PMID: 38026201 Free PMC article.
-
A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy.Chem Sci. 2017 May 1;8(5):3434-3443. doi: 10.1039/c6sc03306g. Epub 2017 Mar 14. Chem Sci. 2017. PMID: 28507715 Free PMC article.
References
-
- Kerwar SS, Bauman N, Oronsky AL, Sloboda AE. Studies on type II collagen induced polyarthritis in rats. Effect of complement depletion. J Immunopharmacol. 1981;3:323–337. - PubMed
-
- Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med. 1956;91:95–101. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical